Oliver Wyman December 23, 2025
Scientific advances amid growing market pressure
The global pharmaceutical industry is entering the second half of the decade with strong scientific momentum, even as structural pressures intensify. Worldwide prescription drug sales are projected to exceed $1.7 trillion by 2030, fueled by continued advances in oncology, immunology, metabolic disease, and rare conditions.
Momentum is especially strong in the newest therapeutic modalities, which are advancing at a remarkable pace. Antibody drug conjugates are growing at over 20% annually, RNA therapeutic pipelines have expanded more than twofold since 2018, and biologics now account for more than half of global prescription medicine revenues.
While these trends signal a period of tremendous opportunity for the industry, the geopolitical and economic environment is becoming more complex....
Today's Sponsors
Today's Sponsor